CN103479900A - Traditional Chinese medicine used for treating athetosis - Google Patents
Traditional Chinese medicine used for treating athetosis Download PDFInfo
- Publication number
- CN103479900A CN103479900A CN201310253282.1A CN201310253282A CN103479900A CN 103479900 A CN103479900 A CN 103479900A CN 201310253282 A CN201310253282 A CN 201310253282A CN 103479900 A CN103479900 A CN 103479900A
- Authority
- CN
- China
- Prior art keywords
- portions
- parts
- grams
- chinese medicine
- athetosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 208000009017 Athetosis Diseases 0.000 title abstract description 12
- 241000005787 Cistanche Species 0.000 claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 241000628997 Flos Species 0.000 claims description 9
- 241000756943 Codonopsis Species 0.000 claims description 7
- 241001057584 Myrrha Species 0.000 claims description 7
- 239000012567 medical material Substances 0.000 claims description 5
- 240000007171 Imperata cylindrica Species 0.000 claims description 3
- 241001078983 Tetradium ruticarpum Species 0.000 claims description 3
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 244000281702 Dioscorea villosa Species 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 241001529739 Prunella <angiosperm> Species 0.000 claims 1
- 239000009636 Huang Qi Substances 0.000 abstract description 6
- 238000002474 experimental method Methods 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 241000185686 Apocynum venetum Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000208253 Gymnema sylvestre Species 0.000 abstract 1
- 244000167230 Lonicera japonica Species 0.000 abstract 1
- 235000017617 Lonicera japonica Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000722949 Apocynum Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 206010008129 cerebral palsy Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 235000015911 Amorpha canescens Nutrition 0.000 description 1
- IRLNKOAURQPXIQ-WWWUCTDISA-N Apiopaeonoside Natural products O=C(C)c1c(O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO[C@H]3[C@H](O)[C@@](O)(CO)CO3)O2)cc(OC)cc1 IRLNKOAURQPXIQ-WWWUCTDISA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 244000012254 Canarium album Species 0.000 description 1
- 235000009103 Canarium album Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 244000107780 Capraria biflora Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 241000208251 Gymnema Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 244000236527 Linum perenne Species 0.000 description 1
- 235000008569 Linum perenne Nutrition 0.000 description 1
- 235000013629 Lippia javanica Nutrition 0.000 description 1
- 241000243684 Lumbricus Species 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- IDZZECHGWAZTIB-NYBIBFQCSA-N Paeonolide Chemical compound COC1=CC=C(C(C)=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H](O)[C@@H](O)CO3)O)O2)O)=C1 IDZZECHGWAZTIB-NYBIBFQCSA-N 0.000 description 1
- IDZZECHGWAZTIB-WPQJODJHSA-N Paeonolide Natural products O=C(C)c1c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]3[C@@H](O)[C@H](O)[C@@H](O)CO3)O2)cc(OC)cc1 IDZZECHGWAZTIB-WPQJODJHSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 241001468611 Polygonatum cyrtonema Species 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000800405 Spatholobus suberectus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IDZZECHGWAZTIB-UHFFFAOYSA-N affinoside Natural products COC1=CC=C(C(C)=O)C(OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)=C1 IDZZECHGWAZTIB-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000010159 dioecy Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000017311 musculoskeletal movement, spinal reflex action Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine used for treating athetosis. The traditional Chinese medicine comprises following ingredients, by weight, 14 portions of apocynum venetum, 12 portions of fructus evodiae, 8 portions of gymnema sylvestre schult, 12 portions of cortex moutan, 10 portions of cortex lycii radicis, 12 portions of lonicera japonica, 10 portions of myrrh, 14 portions of codonopsis pilosula, 12 portions of radix astragali, 14 portions of Chinese yam, 10 portions of caulis spatholobi, 14 portions of rhizoma imperatae, 8 portions of sealwort, 9 portions of desertliving cistanche, 12 portions of semen astragali complanati and 12 portions of spica prunellae. It is proved by clinical experiments that the traditional Chinese medicine is capable of treating athetosis safely and effectively.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of athetosic Chinese medicine for the treatment of.
Background technology
Athetosis (athetosis) is found in multiple encephalopathy, and characteristics are the slow irregular twistings of brothers.Athetosis is far-end of limb migration muscular hypertonia and lower action, occurs slowly as torsion sample that Lumbricus creeps is wriggled, and companion's far-end of limb overextension, as excessively in the wrong as wrist, finger hyperextension etc., and point lentamente one by one flexing in succession; Due to too much autokinesis make to get involved position can not maintain a certain posture or the position.The athetosis type accounts for Their Incidence of Cerebral Palsy type second, and this type take that to be difficult to suppress the limbs involuntary movement by will be principal character, comprises face muscle, invades and whole body, because sounding, structure sound organ is get involved also more, therefore often with aphasis.Pathological changes is at the cerebral deep basal nuclei, and the from outside part of cone is main, accounts for cerebral palsy 20%.
Still lack at present the effective medicine of generally recognized as safe for athetosis.
The present Research of the related medical material of Chinese medicine of the present invention is as follows:
Herba Apocyni veneti [source] Herba Apocyni veneti is Apocynaceae Apocynum crop, perennial wild draft phloem fiber plant.Have another name called wild flax, wild tea, bluish dogbane, Semen astragali sinici etc., mainly be grown in the sandy ground on salt-soda soil, desert or riverbank, gully, hillside.[function cures mainly] cold nature, bitter but sweet flavor, can resolving heat and reducing pathogenic fire, and suppressing the hyperactive liver to relieve the wind syndrome cures mainly the diseases such as headache, dizzy, insomnia; Leaf is sweet containing Herba Apocyni veneti, has cardiotonic, can treat the diseases such as hypertension.
The almost ripe fruit that Fructus Evodiae [source] is rutaceae Fructus Evodiae Evodia rutaecarpa.[function cures mainly] its bitter in the mouth hot in nature is cold, and the merit of heat radiation pain relieving, stopping nausea and vomiting by lowering the adverse flow of QI is arranged, and is used for the treatment of that the liver insufficiency of stomach is cold, the diseases such as the headache due to cloudy turbid superinverse or gastralgia.
Radix Gymnematis Sylvestris [source] medical material Ji Yuan: be root or the browse of dicotyledon medicine asclepiadaceae plant Largeleaf Gymnema.[function cures mainly] clearing away heat and cooling blood; The evacuation of pus detumescence; The pain relieving granulation promoting.The main air pain of dampness syndrome; Laryngopharynx swelling and pain; Scrofula: acute mastitis; Furuncle; Eczema; Innominate toxic swelling; Venom.
The root bark that Cortex Moutan [source] is Ranunculaceae Paeonia plant Paeonia suffruticosa, containing paeonol, paeonolide, volatile oil and plant sterol etc.[function cures mainly] Cortex Moutan reduces blood pressure, eases pain, calm, antiinflammatory and refrigeration function; Various pathogens is had to stronger inhibitory action.It is cool in nature, bitter in the mouth, suffering, and the function heat clearing away, removing heat from blood and blood, the clear stasis of blood, be applicable to thermal man's blood system, sends out speckle, frightened pain, haematemesis, carbuncle and ulcer, the diseases such as traumatic injury.
The root bark that Cortex Lycii [source] is Solanaceae Lycium plant Fructus Lycii, include cinnamic acid, multiple aldehydes matter, betanin and linoleic acid etc.; Cortex Lycii has significant refrigeration function, and its decoct can make blood glucose reduce, and the serum cholesterol of reduction and lipotropic effect are arranged, and the preserved material of Cortex Lycii has the effect reduced blood pressure significantly to animal.It is cold in nature, sweet in the mouth, light.[function cures mainly] removing heat from blood, move back steaming, and clear eliminating the pathogens from the lung heat, be applicable to asthenia hectic fever night sweat, lung-heat cough with asthma, the haematemesis of bleeding due to blood-heat, epistaxis, carbuncle malignant boil and pulmonary tuberculosis and vascular hypertension etc.
Flos Lonicerae [source] Flos Lonicerae is the caprifoliaceae plant alabastrum of Radix Ophiopogonis, containing chlorogenic acid, and inositol, flavones ingredient etc.[function cures mainly] Flos Lonicerae has antiinflammatory and refrigeration function, and infected by influenza and various pathogens, skin pathomycete have inhibitory action, have reflected the heat-clearing toxin-expelling functions of Flos Lonicerae.It is cold in nature, sweet in the mouth, and the function heat clearing away, removing toxic substances, be applicable to the epidemic febrile disease heating, toxic-heat and blood stasis, the disease of the hyperactivity of toxic heat such as skin ulcer, carbuncle, furuncle and phyma.
Myrrha [source] Chinese olive tree section plant Herba Violae tree, Ha Didingshu, the oleo-gum-resin that trunk section oozes out.Be divided into natural Myrrha and gum opoponax.[function cures mainly] the blood blood stasis removing that falls apart, subduing swelling and relieving pain.Control traumatic injury, incised wound, muscles and bones, all pains of trusted subordinate, lump in the abdomen, amenorrhea, ulcer sore pain, anal fistula, diseases of the eye.
Radix Codonopsis [source] Chinese medicine Radix Codonopsis is that campanulaceae herbaceos perennial [function cures mainly] has invigorating the spleen and replenishing QI, the effect of spleen invigorating lung benefiting.Enhancing immunity, blood vessel dilating, blood pressure lowering, improve microcirculation, strengthen the effects such as hemopoietic function
The root that the Radix Astragali [source] is leguminous plant Radix Astagali or Radix Astragali.Remove fibrous root and root head, dry, section, give birth to and use or processed with honey use.[function cures mainly] has the enhancing human body immunity function, protects the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely.
Rhizoma Dioscoreae [source] herbaceos perennial, stem is overgrow, and often is with purple, and tuber is cylindrical, and leaf is to life, avette or oval, flower milky, dioecism.Starch-containing and the protein of tuber.[function cures mainly] spleen reinforcing nourishing the stomach, the lung benefiting that promotes the production of body fluid, the kidney invigorating arresting seminal emission.For insufficiency of the spleen lack of appetite, incessant chronic diarrhea, the deficiency of the lung is breathed with cough, emission due to deficiency of the kidney, and leukorrhagia, frequent micturition, deficiency-heat is quenched one's thirst.
The dry rattan of Caulis Spatholobi [source] leguminous plant spatholobus suberectus Spatholobus suberectus Dunn.[function cures mainly] property is sweet, temperature.Return liver, kidney channel.Function cures mainly: enrich blood, invigorate blood circulation, dredging collateral.For menoxenia, blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia.
Rhizoma Imperatae [source] grass perennial herb Herba Imperatae (formal name used at school: rhizome Imperata cylindrica).Two seasons of spring and autumn excavate.Dry.Remove fibrous root and membranous sheath, cutting is given birth to and is used or parch to black use.[function cures mainly] removing heat from blood, hemostasis, heat clearing away, diuresis.Control the calentura excessive thirst.
Rhizoma Polygonati [source] has another name called Rhizoma Polygonati Cirrhifolii, Caput Gallus domesticus ginseng.The dry rhizome of liliaceous plant Yunnan Rhizoma Polygonati, Rhizoma Polygonati or Polygonatum cyrtonema Hua.With rhizome, be used as medicine.[function cures mainly] has boosting qi and nourishing yin, spleen invigorating, lung moistening, kidney benefiting functions.Be used for the treatment of weakness of the spleen and stomach, fatigue and asthenia, xerostomia lack of appetite, deficiency of the lung cough caused by dryness, asthenia of essence and blood, the interior-heat disease such as quench one's thirst.
The fleshy stem that Herba Cistanches [source] is orobanchaceae plant cistanche or Herba Cistanches, fan's Herba Cistanches etc.[function cures mainly] reinforcing the kidney and supporting YANG, loosening bowel to relieve constipation, hard masses softening and resolving.
The mature seed that Semen Astragali Complanati [source] is pulse family annual herb plant astragatus complanatus, tap plant when the time of the year when autumn changes into winter fruit maturation not yet ftractures, and dries, and lays seed.Give birth to or fry and use.[function cures mainly] tonifying liver, kidney tonifying, improving eyesight, controlling nocturnal emission with astringent drugs.The treating the liver kidney deficiency, soreness of waist and knee joint, blurred vision, seminal emission premature ejaculation, frequent micturition, the enuresis, hematuria, leucorrhea.
Flowers or herb that Spica Prunellae [source] Spica Prunellae is the labiate Spica Prunellae, include triterpenoid saponin and glycoside unit oleanolic acid thereof, volatile oil and vitamin, potassium chloride etc.[function cures mainly] it is cold in nature, bitter in the mouth, suffering, and the function clearing away liver-fire, Disperse hepatic depression, blood pressure lowering, be applicable to the conjunctival congestion and swelling pain due to flaming up of liver-fire, ophthalmalgia, photophobia is shed tears, headache, dizzy etc.; For the scrofula due to phlegm-fire pent-up, goiter etc.
Summary of the invention
The present invention aims to provide a kind of athetosic Chinese medicine for the treatment of, and by selecting suitable medical material and proportioning thereof, reaches the athetosic purpose of safe and effective healing.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind ofly treat athetosic Chinese medicine, it is characterized in that, be prepared from by the medical material of following weight proportion: 14 parts of Herba Apocyni venetis, 12 parts of Fructus Evodiaes, 8 parts of Radix Gymnematis Sylvestriss, 12 parts of Cortex Moutans, 10 parts of Cortex Lycii, 12 parts of Flos Loniceraes, 10 parts of Myrrhas, 14 parts of Radix Codonopsis, 12 parts of the Radixs Astragali, 14 parts of Rhizoma Dioscoreaes, 10 parts of Caulis Spatholobis, 14 parts of Rhizoma Imperataes, 8 parts of Rhizoma Polygonatis, 9 parts of Herba Cistanches, 12 parts of Semen Astragali Complanatis, 12 parts of Spica Prunellaes.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
The inventor collects 80 routine athetosic out-patients in 2010 altogether between year JIUYUE of June-2011, age 12-47 year, course of disease 0.5-7.Be divided at random: treatment group 50 examples, blank group 30 examples.The data there was no significant differences such as two groups of ages, the state of an illness, have comparability.
2, test method
2.1 the capsule that the oral the present invention for the treatment of group makes according to specific embodiment 1, sooner or later respectively once.30 days courses for the treatment of.
2.2 blank group oral placebo capsule, sooner or later respectively once.30 days courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, and the test chamber inspection is normal.Take a turn for the better: clinical symptom relief, the state of an illness is controlled, and lab testing improves or is normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
3.2 treatment statistical result is in Table 1.
Table 1 liang group curative effect relatively
Visible, the medicine that the present invention makes can safe and effectively be controlled athetosis.
The specific embodiment
In order to understand better and to implement the present invention, below in conjunction with specific embodiment, further illustrate the present invention.
Specific embodiment 1
Take: Herba Apocyni veneti 14 grams, Fructus Evodiae 12 grams, Radix Gymnematis Sylvestris 8 grams, Cortex Moutan 12 grams, Cortex Lycii 10 grams, Flos Lonicerae 12 grams, Myrrha 10 grams, Radix Codonopsis 14 grams, the Radix Astragali 12 grams, Rhizoma Dioscoreae 14 grams, Caulis Spatholobi 10 grams, Rhizoma Imperatae 14 grams, Rhizoma Polygonati 8 grams, Herba Cistanches 9 grams, Semen Astragali Complanati 12 grams, Spica Prunellae 12 grams, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, drying, incapsulate shell, must meet the capsule of 1 day consumption of normal adult.
Be used for the treatment of athetosis.Oral, every bu is taken for twice sooner or later.
Specific embodiment 2
Take: Herba Apocyni veneti 14 grams, Fructus Evodiae 12 grams, Radix Gymnematis Sylvestris 8 grams, Cortex Moutan 12 grams, Cortex Lycii 10 grams, Flos Lonicerae 12 grams, Myrrha 10 grams, Radix Codonopsis 14 grams, the Radix Astragali 12 grams, Rhizoma Dioscoreae 14 grams, Caulis Spatholobi 10 grams, Rhizoma Imperatae 14 grams, Rhizoma Polygonati 8 grams, Herba Cistanches 9 grams, Semen Astragali Complanati 12 grams, Spica Prunellae 12 grams, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, pulverize, must meet the powder of 1 day consumption of normal adult.
Be used for the treatment of athetosis.Oral, every bu is taken for twice sooner or later.
Specific embodiment 3
Take: Herba Apocyni veneti 14 grams, Fructus Evodiae 12 grams, Radix Gymnematis Sylvestris 8 grams, Cortex Moutan 12 grams, Cortex Lycii 10 grams, Flos Lonicerae 12 grams, Myrrha 10 grams, Radix Codonopsis 14 grams, the Radix Astragali 12 grams, Rhizoma Dioscoreae 14 grams, Caulis Spatholobi 10 grams, Rhizoma Imperatae 14 grams, Rhizoma Polygonati 8 grams, Herba Cistanches 9 grams, Semen Astragali Complanati 12 grams, Spica Prunellae 12 grams, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, drying, then add appropriate dextrin and correctives, and according to this area common process, to granulate, packing, can make the granule that meets 1 day consumption of normal adult.
Be used for the treatment of athetosis.Oral, every bu is taken for twice sooner or later.
Claims (1)
1. treat athetosic Chinese medicine for one kind, it is characterized in that, be prepared from by the medical material of following weight proportion: 14 parts of Herba Apocyni venetis, 12 parts of Fructus Evodiaes, 8 parts of Radix Gymnematis Sylvestriss, 12 parts of Cortex Moutans, 10 parts of Cortex Lycii, 12 parts of Flos Loniceraes, 10 parts of Myrrhas, 14 parts of Radix Codonopsis, 12 parts of the Radixs Astragali, 14 parts of Rhizoma Dioscoreaes, 10 parts of Caulis Spatholobis, 14 parts of Rhizoma Imperataes, 8 parts of Rhizoma Polygonatis, 9 parts of Herba Cistanches, 12 parts of Semen Astragali Complanatis, 12 parts of Spica Prunellaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310253282.1A CN103479900B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine used for treating athetosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310253282.1A CN103479900B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine used for treating athetosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103479900A true CN103479900A (en) | 2014-01-01 |
| CN103479900B CN103479900B (en) | 2015-02-04 |
Family
ID=49820713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310253282.1A Expired - Fee Related CN103479900B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine used for treating athetosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103479900B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810814A (en) * | 2010-04-28 | 2010-08-25 | 史建钢 | Medicament for curing cerebral palsy, hyperkinetic syndrome and dementia and preparation method thereof |
| CN103007062A (en) * | 2012-12-27 | 2013-04-03 | 邢德忠 | Chinese medicinal preparation for treating cerebral thrombosis |
| CN103110812A (en) * | 2012-12-24 | 2013-05-22 | 原志成 | Medicament for treating infantile cerebral palsy and preparation method thereof |
-
2013
- 2013-06-24 CN CN201310253282.1A patent/CN103479900B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810814A (en) * | 2010-04-28 | 2010-08-25 | 史建钢 | Medicament for curing cerebral palsy, hyperkinetic syndrome and dementia and preparation method thereof |
| CN103110812A (en) * | 2012-12-24 | 2013-05-22 | 原志成 | Medicament for treating infantile cerebral palsy and preparation method thereof |
| CN103007062A (en) * | 2012-12-27 | 2013-04-03 | 邢德忠 | Chinese medicinal preparation for treating cerebral thrombosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103479900B (en) | 2015-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103655979A (en) | Traditional Chinese medicine composition for treating conjunctivitis | |
| CN105853696A (en) | Fire clearing, liver nourishing and eyesight improving pharmaceutical composition for treating eye diseases | |
| CN102940802B (en) | Traditional Chinese medicine composition for treating hematuria | |
| CN104873805A (en) | Traditional Chinese medicine preparation for treating cold and preparation method and application | |
| CN103520352B (en) | The Chinese medicine for the treatment of stasis blocking venation pattern of syndrome obstruction of qi in the chest and cardialgia | |
| CN107213360A (en) | A kind of Chinese medicine composition for treating heavy myasthenia | |
| CN102935170B (en) | Chinese medicament for treating suppurative pylephlebitis | |
| CN103479900B (en) | Traditional Chinese medicine used for treating athetosis | |
| CN101085281A (en) | Traditional Chinese medicine for curing chronic nephritis | |
| CN104606395A (en) | Traditional Chinese medicine prescription treating menstrual fever | |
| CN104800319A (en) | Traditional Chinese medicine for treating uterus fibroids | |
| CN103330833B (en) | Traditional Chinese medicine for treating great occipital neuralgia | |
| CN103948856A (en) | Traditional Chinese medicament for treating artories and veims stasis syndrome chest stuffiness and pains | |
| CN103071119B (en) | Traditional Chinese medicine for treating cholestatic jaundice | |
| CN102920980B (en) | Traditional Chinese medicine for treating retroperitoneal lymphadenitis | |
| CN108714167B (en) | A Chinese medicinal preparation for external use for treating vitiligo, and its preparation method | |
| CN105412830A (en) | Medicine for treating acute icteric hepatitis and preparation method thereof | |
| CN103356809A (en) | Traditional Chinese medicine for treating cerebral infarction | |
| CN103536734B (en) | A kind of Chinese medicine for the treatment of the forgetful disease of deficiency of both the heart and spleen pattern of syndrome | |
| CN104027567A (en) | Traditional Chinese medicine (TCM) used in intensive care unit (ICU) wards for treating sepsis and preparation method thereof | |
| CN103520568B (en) | A kind of Chinese medicine for the treatment of the qi depression to blood stasis pattern of syndrome thoracic obstruction | |
| CN104225177A (en) | Traditional Chinese medicine for treating kidney vacuity and marrow depletion type tinnitus cerebri | |
| CN103816442B (en) | A kind of Chinese medicine for the treatment of the urinary tract infection caused by diabetes | |
| CN104208218B (en) | A kind of Chinese medicine for the treatment of stagnant heat type amenorrhea | |
| CN102920895A (en) | Traditional Chinese medicine for treating alveolar hypoventilation syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG WEI Free format text: FORMER OWNER: CHEN YINGDI Effective date: 20141223 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Wei Inventor after: Yin Jianjun Inventor after: Yin Zhe Inventor before: Chen Yingdi |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 315175 NINGBO, ZHEJIANG PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: CHEN YINGDI TO: ZHANG WEI YIN JIANJUN YIN ZHE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20141223 Address after: 266071 Department of emergency, Qingdao municipal hospital, 5 Donghai Middle Road, Shandong, Qingdao Applicant after: Zhang Wei Address before: State Road 315175 Zhejiang Lianfeng Dan district city of Ningbo province No. 889 Applicant before: Chen Yingdi |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150204 Termination date: 20150624 |
|
| EXPY | Termination of patent right or utility model |